The stock has a 36-month beta value of 1.94. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NEXI is 0.79M, and at present, short sellers hold a 4.46% of that float. On April 09, 2024, the average trading volume of NEXI was 1.10M shares.
NEXI) stock’s latest price update
Neximmune Inc (NASDAQ: NEXI)’s stock price has soared by 15.90 in relation to previous closing price of 3.71. Nevertheless, the company has seen a loss of -22.94% in its stock price over the last five trading days. InvestorPlace reported 2024-01-09 that Shares of NexImmune (NASDAQ: NEXI ) stock are skyrocketing higher ahead of the company’s special meeting of stockholders. The meeting was initially set for Dec. 21 with a record date of Nov. 6.
NEXI’s Market Performance
Neximmune Inc (NEXI) has seen a -22.94% fall in stock performance for the week, with a -31.75% decline in the past month and a -30.42% plunge in the past quarter. The volatility ratio for the week is 16.82%, and the volatility levels for the past 30 days are at 8.57% for NEXI. The simple moving average for the past 20 days is -22.66% for NEXI’s stock, with a -25.53% simple moving average for the past 200 days.
Analysts’ Opinion of NEXI
Many brokerage firms have already submitted their reports for NEXI stocks, with Raymond James repeating the rating for NEXI by listing it as a “Outperform.” The predicted price for NEXI in the upcoming period, according to Raymond James is $30 based on the research report published on April 01, 2021 of the previous year 2021.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see NEXI reach a price target of $35. The rating they have provided for NEXI stocks is “Overweight” according to the report published on March 09th, 2021.
Barclays gave a rating of “Overweight” to NEXI, setting the target price at $35 in the report published on March 09th of the previous year.
NEXI Trading at -41.96% from the 50-Day Moving Average
After a stumble in the market that brought NEXI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.01% of loss for the given period.
Volatility was left at 8.57%, however, over the last 30 days, the volatility rate increased by 16.82%, as shares sank -28.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.34% lower at present.
During the last 5 trading sessions, NEXI fell by -22.94%, which changed the moving average for the period of 200-days by -34.10% in comparison to the 20-day moving average, which settled at $5.47. In addition, Neximmune Inc saw 93.69% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NEXI starting from Roemer Alan S., who sale 3,992 shares at the price of $1.94 back on Nov 22 ’23. After this action, Roemer Alan S. now owns 0 shares of Neximmune Inc, valued at $7,758 using the latest closing price.
Roemer Alan S., the Director of Neximmune Inc, sale 3,833 shares at $2.16 during a trade that took place back on Nov 21 ’23, which means that Roemer Alan S. is holding 3,992 shares at $8,287 based on the most recent closing price.
Stock Fundamentals for NEXI
The total capital return value is set at -5.37. Equity return is now at value -156.79, with -121.49 for asset returns.
Based on Neximmune Inc (NEXI), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -60.73. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is 0.17.
Currently, EBITDA for the company is -62.51 million with net debt to EBITDA at 0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.66.
Conclusion
To sum up, Neximmune Inc (NEXI) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
